![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Crospovidone
Dosage Form: Tablet
Category: Disintegrants & Superdisintegrants
Technical Specifications: NA
Applications:
Ingredient(s): Polyvinylpyrrolidone
Category: Fillers, Diluents & Binders
Technical Specifications: NA
Applications:
KoVidone® K30 is used as a binder for tablets and capsules.
Ingredient(s): Polyvinylpyrrolidone K30
Category: Fillers, Diluents & Binders
Technical Specifications: NA
Applications:
Ingredient(s): Hydrogen Peroxide Excipient, KoVidone K30
Category: Co-Processed Excipients
Technical Specifications: NA
Applications:
Ingredient(s): Hydrogen Peroxide Excipient, KoVidone K30
Category: Co-Processed Excipients
Technical Specifications: NA